SANGAMO THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 41918000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | SANGAMO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:50.937777+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/74ba90fa-26a1-4994-8de6-c133f8c31bce
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-013088Retrieved: 2026-08-19T09:41:50.937777+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001233/cash-and-equivalents/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/74ba90fa-26a1-4994-8de6-c133f8c31bce
History
- no predecessors — first report